Tender Offer | ₹137.75 Crores | Listed at BSE, NSE | Tue, Apr 12, 2022 - Wed, Apr 27, 2022
FDC Ltd. Buyback is a tender offer for the repurchase of up to 0.29 crore equity shares at a buyback price of ₹475 per share with a face value of ₹1 per share, aggregating to ₹137.75 crores.
The record date for determining eligible shareholders is Feb 19, 2022. Shareholders holding equity shares as on the record date are eligible to participate in the buyback.
The buyback opens on Apr 12, 2022 and closes on Apr 27, 2022, with the last date for receipt of tender forms being Apr 29, 2022.
The finalisation of buyback acceptance is expected on May 5, 2022, followed by settlement of bids on May 9, 2022.
Sundae Capital Advisors Pvt.Ltd. is the Manager to the Buyback and MUFG Intime India Pvt.Ltd. is the Registrar and Arete Securities Limited is the Registered Broker to the Buyback.
Investors are advised to refer to the FDC Ltd. Letter of Offer for detailed information, including eligibility criteria, entitlement ratio, acceptance methodology, and tax implications.
Offer Opening Date
Tue, Apr 12, 2022
Offer Closing Date
Wed, Apr 27, 2022
Buyback Price
₹475 per share
Record Date
February 19, 2022
| Category | Entitlement Ratio of Buyback |
|---|---|
| Reserved Category for Small Shareholders | 20 Equity Shares for every 307 Equity Shares held on the Record Date. |
| General Category for all other Eligible Shareholders | 9 Equity Shares for every 592 Equity Shares held on the Record Date. |
| Particulars | For the year/period ended (Rs. in Crores) | ||
|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Total Income | 1,422.60 | 1,413.75 | 1,130.67 |
| Profit After Tax | 294.49 | 246.78 | 171.54 |
| Net Worth | 1717.75 | 1,542.59 | 1,432.99 |
| Reserves and Surplus | 1,700.87 | 1,525.49 | 1,415.47 |
FDC Limited is engaged in manufacturing and marketing Oral Rehydration Salts and Ophthalmic. The company has a diversified product portfolio in various therapeutic areas, i.e. Oral Rehydration Salts, Ophthalmology, Dermatology, Antibiotics, Antivirals, Cardiovascular, and Anti-diabetes. It also manufactures Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms. It offers 300+ products in India and also exports to 50+ countries.
The firm's manufacturing facilities are situated at Roha, Waluj, and Sinnar in Maharashtra, Baddi in Himachal Pradesh, and Verna in Goa.
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jan-2022 | 323.15 | 277.60 | 299.33 |
| Dec-2021 | 313.40 | 273.00 | 289.26 |
| Nov-2021 | 335.70 | 270.00 | 298.73 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Jan-2022 | 322.90 | 277.00 | 299.92 |
| Dec-2021 | 313.50 | 272.75 | 292.85 |
| Nov-2021 | 345.00 | 271.80 | 297.10 |
The Buyback aims to:
i) Increase the earnings per share and enhance Return on equity and return on capital employed, Return on Net Worth, Return on assets, etc and long term increase in shareholders' value;
ii) Distribute surplus cash to the shareholders.
FDC Ltd.
B-8, M.I.D.C. Industrial Estate,
Waluj - 431 130, Dist. Aurangabad
Aurangabad, Maharashtra, 431130
Lead Manager(s)
Registered Broker
The FDC Buyback opens on April 12, 2022, and closes on April 27, 2022.
The FDC Buyback last day to buy is not available as of now.
The FDC Buyback is a Tender Offer.
FDC Buyback Schedule
| Buyback Opening Date | April 12, 2022 |
| Buyback Closing Date | April 27, 2022 |
| Last Date for receipt of Tender Forms | April 29, 2022 |
| Finalisation of Buyback Acceptance | May 5, 2022 |
| Last Date for settlment of bids | May 9, 2022 |
| Last Date for Extinguishment of Shares | May 16, 2022 |
The FDC Buyback is being offered at Rs ₹475 per share.
| Category | Entitlement Ratio of Buyback |
|---|---|
| Reserved Category for Small Shareholders | 20 Equity Shares for every 307 Equity Shares held on the Record Date. |
| General Category for all other Eligible Shareholders | 9 Equity Shares for every 592 Equity Shares held on the Record Date. |
The issue size of FDC Buyback is 29,00,000 equity shares at ₹475 per share aggregating up to ₹137.75 Crores.
The Buyback aims to:
i) Increase the earnings per share and enhance Return on equity and return on capital employed, Return on Net Worth, Return on assets, etc and long term increase in shareholders' value;
ii) Distribute surplus cash to the shareholders.
All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.
The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.
The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.
The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.
The FDC Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
